CAS 790241-43-9

1H-Benzimidazole-5-carboximidamide,2-[5-[4-(aminoiminomethyl)phenyl]-2-thienyl]-

Description:

1H-Benzimidazole-5-carboximidamide, 2-[5-[4-(aminoiminomethyl)phenyl]-2-thienyl]- is a complex organic compound characterized by its unique structural features, which include a benzimidazole core and a thienyl group. This compound typically exhibits properties associated with heterocyclic compounds, such as potential biological activity and solubility in various organic solvents. The presence of functional groups like carboximidamide and aminoiminomethyl suggests that it may engage in hydrogen bonding and other intermolecular interactions, which can influence its reactivity and stability. Additionally, the thienyl and phenyl substituents may contribute to its electronic properties, potentially making it a candidate for applications in pharmaceuticals or materials science. The compound's molecular structure allows for various conformations, which can affect its physical properties, such as melting point and solubility. Overall, this compound's characteristics make it of interest for further research, particularly in the fields of medicinal chemistry and organic synthesis.

Formula: C₁₉H₁₆N₆S

2-(5-(4-Carbamimidoylphenyl)thiophen-2-yl)-1H-benzo[D]imidazole-6-carboximidamide dihydrochloride

CAS: 790241-43-9

2-(5-(4-Carbamimidoylphenyl)thiophen-2-yl)-1H-benzo[D]imidazole-6-carboximidamide dihydrochloride is a peptide that can act as an activator and inhibitor of ion channels. It has been shown to bind to the extracellular domain of the potassium channel Kv1.5, which is expressed in neurons and cardiac muscle cells, with a binding affinity of 10 nM. This peptide also binds to the extracellular domain of the human α1A adrenergic receptor with a binding affinity of 8 nM. The amino acid sequence for this compound is H-Tyr-Nle-Gly-Arg-Val-Thr-[linker]-Leu-[linker]-NH2.

Formula: C₁₉H₁₆N₆S

Purity: Min. 95%

Molecular weight: 360.4 g/mol

Ref: 3D-QGB24143

DB818

CAS: 790241-43-9

DB818 is a synthetic Homeobox A9 (HOXA9) inhibitor and can be used for research on the treatment of acute myeloid leukaemia associated with HOXA9 overexpression.

Formula: C₁₉H₁₆N₆S

Purity: 98%

Color and Shape: Solid

Molecular weight: 360.44

Ref: TM-T9958